Literature DB >> 19242899

The protean manifestations of pheochromocytoma.

W M Manger1.   

Abstract

The treacherous and deceptive nature of pheochromocytoma makes it crucial to detect and treat it promptly; otherwise it will almost certainly be fatal from cardiovascular complications or metastases. Hypertension occurring in patients with pheochromocytomas is sustained in about 50% and paroxysmal in the remainder; however, many patients remain normotensive. Hypertension attacks may be precipitated by physical activity, postural changes, anxiety, certain foods or wine, some drugs, operative procedures, etc. Cardinal manifestations are paroxysmal hypertension, headache, palpitations +/- tachycardia, inappropriate sweating; anxiety, tremulousness, pallor (rarely flushing), chest and abdominal pains; nausea and vomiting often occur. Hypercatecholaminemia manifestations are more common and pronounced when paroxysmal hypertension occurs, but persons with familial pheochromocytoma may be asymptomatic. Protean manifestations of pheochromocytoma may simulate many conditions, some of which may have elevated plasma and urine catecholamines and their metabolites. Baro-reflex failure, postural tachycardia syndrome, sleep apnea, carcinoid, renal failure, and pseudopheochromocytoma may be diagnostic challenges. The history, physical examination, biochemical testing (after eliminating interfering drugs, when possible) for plasma and urinary metanephrines can usually establish or exclude presence of pheochromocytomas. Occasionally a clonidine suppression test is needed to differentiate neurogenic from pheochromocytic hypertension. Manifestations suggesting hypercatecholaminemia without hypertension are highly atypical of pheochromocytoma. Pheochromocytoma may present as panic attacks, pre-eclampsia, cardiomyopathy, infection with fever and leucocytosis, diabetes, migraine, shock, Cushing's syndrome, multiple organ failure with lactic acidosis, neurological manifestations, transitory electrocardiogram abnormalities, constipation, intestinal obstruction, visual impairment, convulsions, etc. The key to diagnosis is always to think of pheochromocytoma in the differential diagnosis of hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19242899     DOI: 10.1055/s-0028-1128139

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  21 in total

1.  Pheochromocytoma or Münchausen syndrome: the masquerade is up.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2010-04-27       Impact factor: 4.435

Review 2.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

3.  Malignant pheochromocytoma in the anterior mediastinum with sternal invasion: a case report.

Authors:  Mingzhi Song; Kebin Sun; Tian Xia; Lei Zhou; Yangyang Li; Zhe Sun; Yuchi Zhang; Xianbin Zhang; Ran Sun; Bo Chen; Qingwei Tan
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

6.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

7.  PHEOCHROMOCYTOMA CONCEALED BY CHRONIC METHAMPHETAMINE ABUSE.

Authors:  Georgiana Constantinescu; Steffen Leike; Matthias Gruber; Katharina Langton; Carola Kunath; Mirko Peitzsch; Jaap Deinum; Graeme Eisenhofer; Jacques Lenders
Journal:  AACE Clin Case Rep       Date:  2020-09-21

Review 8.  Labile hypertension: a new disease or a variability phenomenon?

Authors:  Elias Sanidas; Charalampos Grassos; Dimitrios P Papadopoulos; Maria Velliou; Kostas Tsioufis; Marina Mantzourani; Despoina Perrea; Dimitrios Iliopoulos; John Barbetseas; Vasilios Papademetriou
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

9.  The adrenal medulla and extra-adrenal paraganglia: then and now.

Authors:  Arthur S Tischler; Karel Pacak; Graeme Eisenhofer
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 10.  Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.

Authors:  Eduardo E Benarroch
Journal:  Mayo Clin Proc       Date:  2012-11-01       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.